Injective (INJ) Surges 9% Following SEC Transfer Agent Approval

Key Highlights

• INJ token rallied approximately 9% to reach $4.40 following significant regulatory developments
• Injective Institutional Services received SEC registration status as a transfer agent in the United States
• This approval enables securities ownership documentation to be maintained using blockchain technology
• Previous partnerships include collaborations with BlackRock, Nomura’s Laser Digital, and Hamilton Lane
• The platform has also secured registration on Europe’s ESMA Interim MiCA Register

The Injective token experienced a significant price increase of roughly 9%, reaching $4.40, following the announcement that Injective Institutional Services has successfully completed registration with the United States Securities and Exchange Commission as an official transfer agent.

Injective (INJ) Price

Transfer agents serve as custodians of official securities ownership documentation and handle modifications to those records. The SEC permits registered transfer agents to utilize distributed ledger technology for their primary securityholder files. This authorization means ownership documentation can be recorded and maintained natively on blockchain networks.

This development represents a significant milestone for the tokenized securities sector. Traditionally, blockchain platforms record ownership data onchain while the legally binding record remains stored in conventional databases. This separation frequently creates reconciliation challenges between blockchain-based transactions and traditional record-keeping infrastructure.

The registration obtained by Injective specifically addresses this discrepancy. The platform now possesses the authority to maintain official securities documentation directly on its blockchain network, effectively bridging the divide between these two record-keeping approaches.

Compliant Framework for Blockchain-Based Securities

This registration complements Injective Mint, a platform designed to enable issuers to create and oversee assets with built-in compliance mechanisms at the protocol level. Available functionalities include transfer limitations based on holder identity and geographic location, administrative controls assigned by role, the ability to freeze specific addresses, and regulated token creation and redemption processes.

Injective has established a proven history in this domain. The network has facilitated tokenized institutional investment vehicles, publicly traded equity securities, private company shares, and corporate receivables. Previous implementations have included partnerships with Hamilton Lane, BlackRock, and Nomura’s Laser Digital division.

Compliance Efforts Expand Across the Atlantic

The regulatory approval extends beyond American borders. Injective’s INJ MiCA documentation has been added to ESMA’s Interim MiCA Register following successful completion of the mandatory notification and disclosure procedures required throughout Europe.

According to company representatives, both the American transfer agent authorization and the European MiCA registration represent components of a comprehensive initiative to integrate blockchain-based financial systems with the regulatory structures necessary for widespread institutional acceptance.

This news arrived during a particularly active period for cryptocurrency regulation in the United States. President Donald Trump has scheduled meetings with representatives from the SEC, CFTC, and cryptocurrency companies such as Coinbase and Ripple while the CLARITY Act experiences procedural setbacks. Additionally, the SEC published a new regulatory approach for crypto investment contracts earlier this week.

With this registration, Injective enters an exclusive circle of American cryptocurrency organizations that have obtained official transfer agent certification.

The post Injective (INJ) Surges 9% Following SEC Transfer Agent Approval appeared first on Blockonomi.